SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

WOCKHARDT

BSE: 532300 29 Sep 2025
Healthcare
₹ 1511.6
Wockhardt Ltd specializes in Pharmaceuticals within the Healthcare sector.

WOCKHARDT - Share Price & Details

Market Cap
₹21,717
High /Low
1,870 / 915.0
Stock P/E
426.0
Book Value
₹170.0
Dividend Yield
0.0
ROCE
4.4
ROE
₹-0.53
Face Value
5.0
PEG Ratio
17.6
EVEBITDA
₹57.9
Debt
1,796
CMP / FCF
-189.0
Debt to equity
₹0.65
NP Ann
-12.0
High price all time
1,999
Piotroski score
₹5.0
Graham Number
107.0
No. Eq. Shares
16.2
Net CF
₹-428
Net profit
51.0
Price to book value
7.86
Interest Coverage
₹1.28
Low price all time
61.3
Industry PE
33.0
Reserves
₹2,682
Free Cash Flow
₹-508

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
WOCKHARDT LTD.4380.0690.04130.04.2521,717426.0
Eris Lifesciences Limited6013.2999.95786.47.332159755.8
POLY MEDICURE LTD.4251.42879.293840.478.671985555.5

Peer Comparison Chart


About WOCKHARDT

Wockhardt Ltd, with Security Code 532300, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

Wockhardt-Shukra Pharma deal: Pharma majors sign pan-India distribution pact - Details

(13 Sep 2025)
Distribution Deal: According to a PTI report, Shukra Pharma has entered into a pan-India distribution deal with global pharmaceutical and...
Read more →

Shukra Pharmaceuticals inks distribution tie-up with Wockhardt

(13 Sep 2025)
The products include high-quality, advanced anti-infective formulations such as EMROK (Levonadifloxacin) and MIQNAF (Nafithromycin)
Read more →

Shukra Pharma wins rights to distribute Wockhardt advanced anti-infective formulations across India

(12 Sep 2025)
New Delhi: Wockhardt, a global pharma company, has authorised Shukra Pharma to represent, distribute, and manage its products across all...
Read more →

Circuit-to-circuit pharma stock hits upper circuit; here's why

(12 Sep 2025)
The pharma stock has rewarded its investors with significant gains. The scrip has delivered whopping 51 per cent returns in a month and...
Read more →

Shukra Pharma enters into pan-India distribution pact with Wockhardt

(11 Sep 2025)
Shukra Pharmaceuticals on Wednesday said it has entered into a strategic non-exclusive Pan-India distribution arrangement with Wockhardt Ltd...
Read more →

Pharma stock hits upper circuit after signing PAN India Distribution Deal with Wockhardt

(11 Sep 2025)
Synopsis: Shukra Pharmaceuticals hit the upper circuit after partnering with Wockhardt Limited for a PAN India distribution tie-up,...
Read more →